Diet and health risk: Risk patterns and disease-specific associations

American Journal of Clinical Nutrition

Volumn 69, Issue 6, 1999, Pages

  Marshall, James R ^a   Chen, Zhao ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Attributable risk; Disease; Epidemiology; Exposure; Measurement error; Relative risk; Reliability; Validity

Indexed keywords

CONFERENCE PAPER; DIET; DISEASE ASSOCIATION; DOSE RESPONSE; EPIDEMIOLOGICAL DATA; NUTRITION; RELIABILITY; RISK ASSESSMENT;

EID: 0032973552     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.6.1351s     Document Type: Conference Paper

References (21)

1. Giovanucci E, Stampfer MJ, Colditz GA, et al. A comparison of prospective and retrospective assessments of diet in the study of breast cancer. Am J Epidemiol 1993;137:502-12.
2. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-501.
3. Marshall J, Hastrup JL. Mismeasurement and the resonance of strong confounders: uncorrelated errors. Am J Epidemiol 1996;143:1069-78.
4. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
5. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta carotene materially reduce human cancer rates? Nature 1981;290:201-8.
6. Omenn G, Goodman G, Thornquist M, et al. The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high-risk populations: smokers and asbestos-exposed workers. Cancer Res 1994;54(suppl):20385-435.
7. Hennekens CH, Buring JE, Manson J, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1146-9.
8. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
9. London WT, Duan LX, Feitelson MA. The value of hepatitis B antigen as a prognostic marker in the development of hepocellular carcinoma. Int J Cancer 1996;55:571-6.
10. Taubes G. Epidemiology faces its limits. Science 1995;269:164-9.
11. Hill AB. Principles of medical statistics. 8th ed. New York: Oxford University Press, 1966.
12. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven, 1998.
13. Gregorio D, Marshall J, Zielezny M. Fluctuations in relative odds ratios due to variance differences in case-control studies. Am J Epidemiol 1985;121:767-74.
14. Freudenheim J, Marshall J. The problem of profound mismeasurement and the power of epidemiologic studies of diet and cancer. Nutr Cancer 1988;11:143-250.
15. Walker AM, Blettner M. Comparing imperfect measurement exposure. Am J Epidemiol 1983;121:783-90.
16. Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake and risk of breast cancer - a pooled analysis. N Engl J Med 1996;334:356-61.
17. Campbell TC, Junshi C. Diet and chronic degenerative diseases: perspectives from China. Am J Clin Nutr 1994;59(suppl):1153S-61S.
18. Rossouw JE, Finnegan LP, Harlan WR, Finn VW, Clifford C, McGowen JA. The evolution of the Women's Health Initiative: perspectives from the NIH. J Am Med Womens Assoc 1995;50:50-5.
19. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med 1995;332:1245-50.
20. Spiegelman D, Schneeweiss S, McDermott A. Measurement error correction for logistic regression models with an "alloyed gold standard." Am J Epidemiol 1997;145:184-97.
21. Marshall JR. The use of dual or multiple reports in epidemiologic studies. Stat Med 1989;8:1041-9.